ARFID can persist into young adulthood and beyond, significantly disrupting daily life and social functioning
A study published in eBioMedicine found that tirzepatide attenuated dopamine reward signaling in the nucleus accumbens and suppressed alcohol drinking and relapse-like behaviors in rodent models
The search period was restricted to January 1, 2000, through May 6, 2025, as GLP-1 receptor agonists began entering clinical research in the early 2000s
it will not be effective in cases of primary ovarian failure or primary testicular failure where the glands cannot respond
Similarly, tests for nutritional deficiency including multiple tests on vitamins and metabolites are not necessary
They dont go through clinical trials, and theyre not evaluated by the FDA for safety or efficacy